Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

James Larkin

James Larkin

James Larkin

The Royal Marsden
London

United Kingdom

Professor James Larkin is a Medical Oncologist specialising in the treatment of melanoma and cancers of the kidney.

Professor Larkin grew up in North Cornwall before taking a first in Natural Sciences from Cambridge University. He undertook clinical training at Oxford University, qualifying in 1996. He underwent general medical training in London and in 2001 won a Medical Research Council Fellowship for a Clinician, carrying out laboratory research at the Institute of Cancer Research leading to a PhD. Specialist training was completed at The Royal Marsden and he was appointed a Consultant in 2008.

His research interests involve trying to understand cancer and its consequences better, as well as developing improved treatments, particularly with targeted therapies and immunotherapies. In the past he has served on the Medical Oncology Specialist Advisory Committee for the Joint Royal Colleges of Physicians Training Board, as the National Institute for Health Research (NIHR) National Specialty Lead for Early Phase Oncology Trials and as Vice Chair of the CRUK Clinical Research Committee as well as Chair of the NCRI Renal Cancer Clinical Studies Group, The Royal Marsden/Institute of Cancer Research Committee for Clinical Research and the CRUK Clinical Research Monitoring Panel.

In 2018 he was elected as a Fellow of the Academy of Medical Sciences and in 2020 as an NIHR Senior Investigator. From 2022 he has led the Cancer Immunotherapy Theme at The Royal Marsden/Institute of Cancer Research NIHR Biomedical Research Centre. Professor Larkin serves as a medical advisor to the patient advocacy group Melanoma UK, as a trustee of the Kidney Cancer Support Network and sits on the Medical Advisory Board of the International Kidney Cancer Coalition.

Last update: June 2023

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.